CN102641430A - Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) - Google Patents
Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) Download PDFInfo
- Publication number
- CN102641430A CN102641430A CN201210147298XA CN201210147298A CN102641430A CN 102641430 A CN102641430 A CN 102641430A CN 201210147298X A CN201210147298X A CN 201210147298XA CN 201210147298 A CN201210147298 A CN 201210147298A CN 102641430 A CN102641430 A CN 102641430A
- Authority
- CN
- China
- Prior art keywords
- treatment
- parts
- chinese medicine
- traditional chinese
- kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000007342 Diabetic Nephropathies Diseases 0.000 title claims abstract description 19
- 208000033679 diabetic kidney disease Diseases 0.000 title claims abstract description 19
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 7
- 241000600871 Euryale <brittle star> Species 0.000 claims description 6
- 241001446509 Psoralea Species 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 24
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 210000002700 urine Anatomy 0.000 abstract description 12
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 210000004072 lung Anatomy 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000007812 deficiency Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 102000009027 Albumins Human genes 0.000 abstract 3
- 108010088751 Albumins Proteins 0.000 abstract 3
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 241000717675 Clerodendranthus Species 0.000 abstract 1
- 244000268590 Euryale ferox Species 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 229940122069 Glycosidase inhibitor Drugs 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- CLGPABLPZDWCHL-UHFFFAOYSA-N benzoic acid;n-methylmethanamine Chemical class CNC.OC(=O)C1=CC=CC=C1 CLGPABLPZDWCHL-UHFFFAOYSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003316 glycosidase inhibitor Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Abstract
The invention discloses traditional Chinese medicine decoction for treating diabetic nephropathy (DN). In the view of traditional Chinese medicine, the pathogenesis of the DN mainly relates to lungs, spleens, kidneys and other viscera; and after the course of disease lasts for a long time, the lung and spleen are damaged, and then the disease spreads to the kidney after a long time, so that the deficiency and malfunction of the kidney are caused, and turbidity is accumulated to cause toxicity and then invades into collaterals to cause blood stasis which then blocks the collaterals, thereby causing the DN. Therefore, according to the symptomatic treatment in traditional Chinese medicine science, the decoction is prepared in a manufacturing laboratory in a hospital from the following selected traditional Chinese medicines, such as fructus psoraleae, fructus lycii, semen euryales, prepared rehmannia root, fructus corni, raw glycyrrhiza, semen cuscutae, salvia miltiorrhiza, spicate clerodendranthus herb, herba dendrobii and atractylodes macrocephala, with the functions of invigorating the circulation of blood, alleviating the turbidity and tonifying the kidney. Clinical tests prove that the total effective rate of the decoction reaches 92.86% and is obviously higher than that of a control group, the 24h urine protein and ALB (albumin) of a treatment group are obviously reduced after treatment compared with those before treatment, the after-treatment 24h urine protein of the treatment group is reduced obviously compared with that of the control group, and the urine ALB is reduced obviously after treatment compared with that before the treatment, therefore, the traditional Chinese medicine decoction is worthy of clinical promotion and application.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine decoction of treating diabetic nephropathy.
Background technology
Diabetics forms huge colony in China; Prolongation along with the diabetes state of an illness; The performance of suffering from a deficiency of the kidney all appears in a lot of diabeticss, and diabetic nephropathy (DN) becomes one of diabetes severe complication, and it can cause the glomerule infringement; Final clinical manifestation is that the urinaryalbumin discharge increases, and albuminuria can be accelerated the renal damage process.
The medication treatment of diabetic nephropathy is very crucial, but if inappropriate medication is easy to cause medicine property renal damage.Medicine property renal damage is meant the disease by the various kidney damages of drug-induced, and kidney is thing metabolism of medicine property renal damage and excretory vitals, mainly shows as nephrotoxicity and anaphylaxis.So when the treatment diabetic nephropathy, improve understanding, to reduce the incidence rate of medicine property renal damage to dealed with medicine went.Chinese herbal medicine is little with its toxicity, side effect is little, clinically is used to treat diabetic nephropathy and can effectively alleviates the infringement of medicine to kidney.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine decoction of treating diabetic nephropathy.Chinese medicine thinks, it is dirty that the DN pathogenesis relates generally to lung spleen kidney etc., the course of disease with the passing of time, the lung spleen is impaired, for a long time sick and kidney, the dysfunction of the kidney in storing essence of suffering from a deficiency of the kidney, precise and tiny solid; The cohesion of sick turbid pathogen for a long time turbidly gathers to become poison, and turbidity is gone into network, stagnation of blood stasis, and it is real to belong to the deficiency in origin table, the network of suffering from a deficiency of the kidney resistance phlegm-turbidity and blood stasis knot, the state of an illness is very grave day by day.Thereby should to treat in the stage with the activating blood circulation to eliminate turbid the kidney invigorating be main.
The objective of the invention is to realize that through following technical scheme the Chinese medicine decoction of this treatment diabetic nephropathy is processed by following parts by weight of Chinese traditional medicine: Fructus Psoraleae 8-10 part, Fructus Lycii 7-9 part, Semen Euryales 7-9 part, Radix Rehmanniae Preparata 12-13 part, Fructus Corni 7-10 part, Radix Glycyrrhizae 5-7 part, Semen Cuscutae 9-12 part, Radix Salviae Miltiorrhizae 10-12 part, Herba clerodendranthi spicati 10-13 part, Herba Dendrobii 8-10 part, Rhizoma Atractylodis Macrocephalae 7-9 part.
Preferably, the Chinese medicine decoction of this treatment diabetic nephropathy is processed by following parts by weight of Chinese traditional medicine: 9 parts of Fructus Psoraleaes, 8 parts of Fructus Lycii, 8 parts of Semen Euryaless, 11 parts of Radix Rehmanniae Preparata, 9 parts of Fructus Corni, 6 parts of Radix Glycyrrhizae, 11 parts of Semen Cuscutae, 11 parts of Radix Salviae Miltiorrhizaes, 12 parts of Herba clerodendranthi spicati, 9 parts of Herba Dendrobiis, 8 parts of the Rhizoma Atractylodis Macrocephalaes.
To add medicine to being decocted in water for oral dose 1 dose of every day.7 days was 1 course of treatment, took effect about 3 courses of treatment.
In the side: Fructus Psoraleae: return kidney channel, reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma;
Fructus Lycii: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, blood-enriching tranquillizing, promoting the production of body fluid to quench thirst, nourishing the lung to arrest cough;
Semen Euryales: stomach, lung, kidney, supplementing the kidney to control the nocturnal, invigorating the spleen to arrest diarrhea, eliminating dampness and arresting leucorrhea;
Radix Rehmanniae Preparata: return liver, kidney channel, the YIN nourishing of enriching blood, beneficial essence is filled out marrow;
Fructus Corni: liver and kidney tonifying, essence astringing and desertion stemming is used for vertigo and tinnitus, soreness of waist and knee joint, interior-heat is quenched one's thirst;
Radix Glycyrrhizae: GUIXIN, spleen, lung, stomach warp, the spleen reinforcing stomach function regulating, QI invigorating is multiple, weakness of the spleen and stomach; Semen Cuscutae: go into liver, kidney channel, invigorating the liver and kidney, beneficial marrow is controlled soreness of waist and knee joint, and seminal emission is quenched one's thirst;
Radix Salviae Miltiorrhizae: GUIXIN, pericardium, Liver Channel, blood circulation promoting and blood stasis dispelling, nourishing blood to tranquillize the mind, removing heat from blood repercussive effect.
Herba clerodendranthi spicati: clearing heat and expelling damp, calculus diuretic, treatment acute and chronic nephritis;
Herba Dendrobii: return through stomach lung, kidney, replenishing YIN and removing heat, reinforcing stomach reg fluid;
The Rhizoma Atractylodis Macrocephalae: return spleen, stomach warp, invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, insufficiency of the spleen lack of appetite, edema.
Clinical data
1, physical data is divided into two groups at random with all selected patient's 220 examples.Because of going on business, leave under order, move, merge acute complications and adverse effect and TD is observed 20 examples in the therapeutic process, wherein 16 examples are organized in treatment; Matched group 4 examples are rejected from treatment group and matched group case, final complete effective case 200 examples; 140 examples are organized in treatment, male 64 examples, women 76 examples; 35～76 years old age, average 55.5 years old; Course of disease 4-18, average 9 years.Matched group 60 examples, male 22 examples, women 38 examples; 36～77 years old age, average 56.5 years old; The course of disease 3～17 years, average 7.5 years.Through statistical analysis, there are no significant (P＞0.05) for difference on two groups of sexes, age, the course of disease, has comparability.
2, Therapeutic Method: the treatment group is taken Chinese medicine decoction of the present invention, and 1 dose of every day, 7 days was 1 course of treatment; Matched group is taken sulphanylureas, biguanides, glycosidase inhibitor, thiazolidinedione, methyl methylamine benzoic acid derivative and insulin injection, and 7 days is a course of treatment, two groups all treat 3 courses of treatment after, observe the curative effect.
3, diagnostic criteria: work out with reference to Ministry of Public Health " new Chinese medicine clinical research guideline ".1. produce effects: the routine urianlysis urine protein reduces by 2 "+", or the twenty-four-hour urine protein quantification reduces >=40%, and renal function is normal.2. effective: the routine urianlysis urine protein reduces by 1 "+", or the twenty-four-hour urine protein quantification reduces＜40%, the normal or improvement of renal function.3. invalid: clinical symptoms or above-mentioned lab testing all do not have the improvement or the person of increasing the weight of.
4, therapeutic outcome
(1) two group of curative effect compares: the statistics curative effect is seen table 1. after three courses of treatment
Table 1 liang group curative effect is [n (%) relatively
Compare * P＜0.05 with matched group
(2) 24h urine protein quantitation, Ccr and ALB relatively obviously reduce (P all＜0.05) before and after the treatment before controlling after each phase 24h urine protein of treatment group, ALB control, and control back 24h urine protein with matched group and more obviously reduce (P＜0.05); Urine ALB treatment back is than preceding significantly descend (P＜0.05) of treatment.The result sees table 2.
Table 2 liang group 24 urine protein quantitation result (x
-± s, mg)
Annotate: 1. compare P＜0.05 with matched group
The specific embodiment
Embodiment one: take by weighing Fructus Psoraleae 9g, Fructus Lycii 8g, Semen Euryales 8g, Radix Rehmanniae Preparata 11g, Fructus Corni 9g, Radix Glycyrrhizae 6g, Semen Cuscutae 11g, Radix Salviae Miltiorrhizae 11g, Herba clerodendranthi spicati 12g, Herba Dendrobii 9g, Rhizoma Atractylodis Macrocephalae 8g.To add medicine to being decocted in water for oral dose, 1 dose of every day, 7 days was 1 course of treatment, serve on 3 courses of treatment.
Embodiment two: take by weighing Fructus Psoraleae 8g, Fructus Lycii 7g, Semen Euryales 7g, Radix Rehmanniae Preparata 12g, Fructus Corni 7g, Radix Glycyrrhizae 5g, Semen Cuscutae 9g, Radix Salviae Miltiorrhizae 10g, Herba clerodendranthi spicati 10g, Herba Dendrobii 8g, Rhizoma Atractylodis Macrocephalae 7g.To add medicine to being decocted in water for oral dose, 1 dose of every day, 7 days was 1 course of treatment, serve on 3 courses of treatment.
Embodiment three: take by weighing Fructus Psoraleae 10g, Fructus Lycii 9g, Semen Euryales 9g, Radix Rehmanniae Preparata 13g, Fructus Corni 10g, Radix Glycyrrhizae 7g, Semen Cuscutae 12g, Radix Salviae Miltiorrhizae 12g, Herba clerodendranthi spicati 13g, Herba Dendrobii 10g, Rhizoma Atractylodis Macrocephalae 9g.To add medicine to being decocted in water for oral dose, 1 dose of every day, 7 days was 1 course of treatment, serve on 3 courses of treatment.
Claims (2)
1. Chinese medicine decoction of treating diabetic nephropathy is characterized in that this Chinese medicine decoction processed by following parts by weight of Chinese traditional medicine: Fructus Psoraleae 8-10 part, Fructus Lycii 7-9 part, Semen Euryales 7-9 part, Radix Rehmanniae Preparata 12-13 part, Fructus Corni 7-10 part, Radix Glycyrrhizae 5-7 part, Semen Cuscutae 9-12 part, Radix Salviae Miltiorrhizae 10-12 part, Herba clerodendranthi spicati 10-13 part, Herba Dendrobii 8-10 part, Rhizoma Atractylodis Macrocephalae 7-9 part.
2. a kind of Chinese medicine decoction of treating diabetic nephropathy according to claim 1 is characterized in that this Chinese medicine decoction processed by following parts by weight of Chinese traditional medicine: 9 parts of Fructus Psoraleaes, 8 parts of Fructus Lycii, 8 parts of Semen Euryaless, 11 parts of Radix Rehmanniae Preparata, 9 parts of Fructus Corni, 6 parts of Radix Glycyrrhizae, 11 parts of Semen Cuscutae, 11 parts of Radix Salviae Miltiorrhizaes, 12 parts of Herba clerodendranthi spicati, 9 parts of Herba Dendrobiis, 8 parts of the Rhizoma Atractylodis Macrocephalaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210147298 CN102641430B (en) | 2012-05-05 | 2012-05-05 | Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210147298 CN102641430B (en) | 2012-05-05 | 2012-05-05 | Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102641430A true CN102641430A (en) | 2012-08-22 |
| CN102641430B CN102641430B (en) | 2013-09-11 |
Family
ID=46654674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210147298 Active CN102641430B (en) | 2012-05-05 | 2012-05-05 | Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102641430B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103272079A (en) * | 2013-05-29 | 2013-09-04 | 宁夏医科大学 | Hui medicine compound for treating diabetic nephropathy and application thereof |
| CN104888082A (en) * | 2015-06-23 | 2015-09-09 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treatment of middle-late diabetic nephropathy merged anemia |
| CN104888083A (en) * | 2015-06-23 | 2015-09-09 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treatment of middle-late diabetic nephropathy merged heart palpitations |
| CN104971290A (en) * | 2015-06-23 | 2015-10-14 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating middle and advanced diabetic nephropathy amalgamative nausea and vomiting |
| CN111529645A (en) * | 2020-04-16 | 2020-08-14 | 上海市嘉定区中医医院 | Medicine for treating kidney deficiency and collateral stasis type diabetic nephropathy in stage IV |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940716A (en) * | 2010-09-19 | 2011-01-12 | 薛红云 | Medicament for treating diabetic nephropathy |
| CN102048958A (en) * | 2011-01-13 | 2011-05-11 | 湖南龙石山铁皮石斛基地有限公司 | Compound dendrobium candidum hypoglycemic composition and preparation method thereof |
-
2012
- 2012-05-05 CN CN 201210147298 patent/CN102641430B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940716A (en) * | 2010-09-19 | 2011-01-12 | 薛红云 | Medicament for treating diabetic nephropathy |
| CN102048958A (en) * | 2011-01-13 | 2011-05-11 | 湖南龙石山铁皮石斛基地有限公司 | Compound dendrobium candidum hypoglycemic composition and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 梁晓平: "糖尿病肾病中医诊治思路", 《中医药临床杂志》 * |
| 王兴柱: "补肾解毒汤并西药常规治疗Ⅳ期糖尿病肾病36例临床研究", 《河北中医》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103272079A (en) * | 2013-05-29 | 2013-09-04 | 宁夏医科大学 | Hui medicine compound for treating diabetic nephropathy and application thereof |
| CN103272079B (en) * | 2013-05-29 | 2015-10-21 | 宁夏医科大学 | A kind of drug compound and application thereof for the treatment of diabetic nephropathy |
| CN104888082A (en) * | 2015-06-23 | 2015-09-09 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treatment of middle-late diabetic nephropathy merged anemia |
| CN104888083A (en) * | 2015-06-23 | 2015-09-09 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treatment of middle-late diabetic nephropathy merged heart palpitations |
| CN104971290A (en) * | 2015-06-23 | 2015-10-14 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating middle and advanced diabetic nephropathy amalgamative nausea and vomiting |
| CN111529645A (en) * | 2020-04-16 | 2020-08-14 | 上海市嘉定区中医医院 | Medicine for treating kidney deficiency and collateral stasis type diabetic nephropathy in stage IV |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102641430B (en) | 2013-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579945A (en) | Traditional Chinese medicinal composition for treating sicca syndrome | |
| CN102302563B (en) | Chinese medicinal composition for treating chronic kidney failure and preparation method thereof | |
| CN102178800B (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102641430B (en) | Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) | |
| CN102579913A (en) | Traditional Chinese medicine composition for treating gouty arthritis | |
| CN104383115A (en) | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation | |
| CN101524494A (en) | Drug for treating gout | |
| CN102784333B (en) | Traditional Chinese medicine composition for curing eczema | |
| CN103705689A (en) | Drug composition for treating gout and gouty arthritis | |
| CN103705687A (en) | Traditional Chinese medicinal composition for preventing and treating early chronic renal failure and preparation method thereof | |
| CN103239579B (en) | Chinese medicine composition for treating acute facioplegia and preparation method thereof | |
| CN102389480A (en) | Chinese medicament for treating hepatitis | |
| CN103735927A (en) | Traditional Chinese medicinal composition for treating acute stage of gout and preparation method thereof | |
| CN103432330B (en) | Traditional Chinese medicine used for treating renal failure and preparation method thereof | |
| CN104645140A (en) | Traditional Chinese medicine composition for treating nephritic syndrome and preparation method of traditional Chinese medicine composition | |
| CN104173818A (en) | Traditional Chinese medicine composition for treating calculus | |
| CN101549045B (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN105963597A (en) | Traditional Chinese medicine for treating oral ulcer | |
| CN102389479A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN103536775A (en) | Traditional Chinese medicine decoction for treating diabetic nephropathy | |
| CN106138494B (en) | Kidney nourishing composition and production method thereof | |
| CN103330846A (en) | Traditional Chinese medicine for treating nephrotic syndrome | |
| CN103071079A (en) | Traditional Chinese medicinal composition for treating prurigo nodularis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU JIAN Free format text: FORMER OWNER: DU XIAOYA Effective date: 20130820 |
|
| C14 | Grant of patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Jian Inventor before: Du Xiaoya |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: DU XIAOYA TO: LIU JIAN Free format text: CORRECT: ADDRESS; FROM: 272002 JINING, SHANDONG PROVINCE TO: 276400 LINYI, SHANDONG PROVINCE |
|
| GR01 | Patent grant | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20130820 Address after: 276400 Linyi health center, Yishui, Shandong, China, Yishui Central Hospital, No. 17, Applicant after: Liu Jian Address before: 272002 Jining first people's Hospital, 6 health Road, Shizhong District, Shandong, Jining Applicant before: Du Xiaoya |
|
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: LIU JIAN Effective date: 20141231 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276400 LINYI, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 276400 Linyi health center, Yishui, Shandong, China, Yishui Central Hospital, No. 17, Patentee before: Liu Jian |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20200703 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200806 Address after: No.2, 1st floor, unit 1, building 2, no.6, Xinhong South 1st lane, Chenghua District, Chengdu City, Sichuan Province 610051 Patentee after: Liu Zhiming Address before: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right |